8C99C7EA.png
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
CN
8C99C7EA.png
CN
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
021-50540520
pvg-banner-275.png banph3-71.jpg

Information and Services

INFORMATION

  • Master e-Classes
  • Typical Case
  • Case Study
  • Assessment Scale
  • Conference Information
  • News Reports
  • Pharmacovigilance
Expert sharing
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Your location:
  • Home
  • Information and Services
  • Conference Information
  • Expert sharing
  • 2022/03/20

    Personalised medicine in Parkinson’s diesease: the rold of the gut-brain axis by Teus Van Laar

  • 2021/07/30

    Evidence from Animal Models of the Role of the Microbiome and APOE in Tau Pathology and Neurodegeneration by David Holtzman

  • 2021/03/14

    Risk Factors and Biomarkers for the REM Sleep Behavior Disorder by Piu Chan

  • 2021/03/14

    The Role of the Microbiome in the Pathogenesis of Parkinson's Disease by Rejko Krueger

  • 2020/07/31

    Michael Heneka:Neuroinflammation Induced by the Immune System May Be Main Cause of AD

  • 2020/07/31

    Bruce Lamb:Identification and Characterization of Immune-Focused Therapeutic Targets in the MODEL-AD and TREAT-AD Consortia

  • 2019/12/29

    Speeches by 7 Industry Experts and Leaders

  • 2019/12/29

    Susan Preschin:Patient Advocacy and Clinical Development

  • 2019/12/29

    Sam Sisodia:The Important Role of Gut Microbiota in AD

  • 2019/12/29

    Jeffery Cummings:Treating Alzheimer’s Disease with GV-971: An International Perspective

  • GV-971

    New hope for treating Alzheimer's disease worldwide

    img1.jpg
    webcode.png
  • Contact us

    Address: 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China

    Phone: 021-50540520

  • Quick Links
    • Home
    • Contact Us
    • Scientific Research Information
    • Pharmacovigilance
    • News Reports
    • Company Website

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

The information on this website is provided as knowledge only and shall not replace medical advice and medical consultation provided by physicians or other qualified healthcare professionals. The information on this website shall not be used for disease diagnosis.

©2022 GreenValley Inc.beian.png 沪公网安备31011502018352号沪ICP备2021021810号-3  Powered by Yongsy

Copyright Notice Legal Notices Terms of use